Page last updated: 2024-11-08

cantharidin and Bone Cancer

cantharidin has been researched along with Bone Cancer in 1 studies

Cantharidin: A toxic compound, isolated from the Spanish fly or blistering beetle (Lytta (Cantharis) vesicatoria) and other insects. It is a potent and specific inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A). This compound can produce severe skin inflammation, and is extremely toxic if ingested orally.
cantharidin : A monoterpenoid with an epoxy-bridged cyclic dicarboxylic anhydride structure secreted by many species of blister beetle, and most notably by the Spanish fly, Lytta vesicatoria. Natural toxin inhibitor of protein phosphatases 1 and 2A.

Research Excerpts

ExcerptRelevanceReference
"Osteosarcoma is the most common primary malignant bone tumor in children and adolescents."1.51Sodium cantharidate targets STAT3 and abrogates EGFR inhibitor resistance in osteosarcoma. ( He, M; Ji, XL, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ji, XL1
He, M1

Other Studies

1 other study available for cantharidin and Bone Cancer

ArticleYear
Sodium cantharidate targets STAT3 and abrogates EGFR inhibitor resistance in osteosarcoma.
    Aging, 2019, 08-15, Volume: 11, Issue:15

    Topics: Adolescent; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Cant

2019